Dr. Reddy's Laboratories LimitedRDYNYSE
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank38
Year-over-Year Change
Year-over-year gross profit growth rate
Percentile
P38
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -2.77% |
| Q3 2025 | -1.00% |
| Q2 2025 | 2.89% |
| Q1 2025 | -3.65% |
| Q4 2024 | 2.69% |
| Q3 2024 | 3.07% |
| Q2 2024 | 11.72% |
| Q1 2024 | -1.71% |
| Q4 2023 | 8899.56% |
| Q3 2023 | -98.81% |
| Q2 2023 | 8937.19% |
| Q1 2023 | -98.91% |
| Q4 2022 | 8490.61% |
| Q3 2022 | -98.21% |
| Q2 2022 | 6707.62% |
| Q1 2022 | -98.66% |
| Q4 2021 | 6785.88% |
| Q3 2021 | -98.38% |
| Q2 2021 | 7282.40% |
| Q1 2021 | -98.69% |
| Q4 2020 | 7894.44% |
| Q3 2020 | -98.66% |
| Q2 2020 | 8.54% |
| Q1 2020 | 7203.02% |
| Q4 2019 | -98.87% |
| Q3 2019 | 39.08% |
| Q2 2019 | -5.67% |
| Q1 2019 | 1.45% |
| Q4 2018 | -0.69% |
| Q3 2018 | 0.82% |
| Q2 2018 | 9.70% |
| Q1 2018 | -11.75% |
| Q4 2017 | 13.28% |
| Q3 2017 | 10.55% |
| Q2 2017 | -5.97% |
| Q1 2017 | -16.97% |
| Q4 2016 | 8.97% |
| Q3 2016 | 10.56% |
| Q2 2016 | -14.56% |
| Q1 2016 | -9.81% |